Circulating Th17, Th22, and Th1 cells are increased in psoriasis - Test2 - elhamkhani - TriplyDB

Circulating Th17, Th22, and Th1 cells are increased in psoriasis

Circulating Th17, Th22, and Th1 cells are increased in psoriasis

http://www.wikidata.org/entity/Q24629315

about

Th17 cells in autoimmune and infectious diseases Peptidoglycan recognition protein Pglyrp2 protects mice from psoriasis-like skin inflammation by promoting regulatory T cells and limiting Th17 responses The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings Lifting the silver flakes: the pathogenesis and management of chronic plaque psoriasis Brodalumab for the Treatment of Psoriasis: A Review of Phase III Trials Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique background Ixekizumab for the Treatment of Psoriasis: A Review of Phase III Trials Old and new treatment targets in axial spondyloarthritis The role of p38 MAPK in the aetiopathogenesis of psoriasis and psoriatic arthritis IL-23/IL-17A Dysfunction Phenotypes Inform Possible Clinical Effects from Anti-IL-17A Therapies IL-17 family: cytokines, receptors and signaling Antifungal Th Immunity: Growing up in Family Seeing through the dark: New insights into the immune regulatory functions of vitamin A Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic Targets T Helper Lymphocyte Subsets and Plasticity in Autoimmunity and Cancer: An Overview IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis Anti-IL-17 phase II data for psoriasis: A review.Increased number of Tc17 and correlation with Th17 cells in patients with immune thrombocytopenia.Inactivation of Notch signaling reverses the Th17/Treg imbalance in cells from patients with immune thrombocytopenia.The Role of IL-17 in the Pathogenesis and Treatment of Psoriasis.Circulating Th17, Th22, and Th1 cells are elevated in the Guillain-Barré syndrome and downregulated by IVIg treatments.The pathogenic role of interleukin-22 and its receptor during UVB-induced skin inflammation.Endogenous n-3 polyunsaturated fatty acids protect against imiquimod-induced psoriasis-like inflammation via the IL-17/IL-23 axis Plasmin plays an essential role in amplification of psoriasiform skin inflammation in mice IL-6 as a druggable target in psoriasis: focus on pustular variants.Different levels of circulating Th22 cell and its related molecules in Graves' disease and Hashimoto's thyroiditis New insights of T cells in the pathogenesis of psoriasis Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis Cytokine requirements for the differentiation and expansion of IL-17A- and IL-22-producing human Vgamma2Vdelta2 T cells.Role of immune-regulatory cells in skin pathology.Triple Cytokine FluoroSpot Analysis of Human Antigen-Specific IFN-γ, IL-17A and IL-22 Responses Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled perio Photo(chemo)therapy reduces circulating Th17 cells and restores circulating regulatory T cells in psoriasis.Increased interleukin-23 receptor(+) T cells in peripheral blood mononuclear cells of patients with systemic lupus erythematosus.Increased expression of IL-22 is associated with disease activity in Behcet's disease.IL-17A production in human psoriatic blood and lesions by CD146+ T cells.Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review.Genetic Epidemiology of Psoriasis

P2860

Q21284677-EF4910D6-80D6-46ED-91C7-37FEE983C6D0 Q24295487-1839B357-AEEF-41FA-AE4C-E81CC643777D Q24623195-5A4E7F2F-D67B-4278-A4B4-CF0E442FA3A1 Q24626968-749C5E13-17E6-4468-9914-5D3AB4A6C086 Q26746100-BA9AB549-BB7A-498B-A127-510D52AE990A Q26765175-04524D71-EB1F-41E2-AF13-C282F65A814D Q26766567-C010091B-3C37-4F39-8409-9C14B5118F72 Q26777906-4B4CBCAE-FF34-4EC8-9816-BC987AFEC8A3 Q26821943-67607324-5EB9-4CDD-90AD-9339C7947423 Q26830943-4C1FC96C-483D-49D2-B89A-6D75CB9B2A63 Q26860251-F3F46B15-85F2-4411-8988-98950E88440F Q27002920-DED70FB0-5CB3-4583-9C32-9E0521F317AF Q27006525-3BD0E369-AF02-4F47-91B8-07CF2218B6AD Q28075992-9A436349-24C5-4F17-998F-04E2CC24BF34 Q28079713-520D4D47-0AFB-4558-90D4-5D3285DF2D10 Q28081582-1E2D8D14-B006-4F08-A9A7-3644881FB9AC Q28268370-CDB2A5C2-596A-418C-8038-E014FC698C1C Q30760301-4E909FA7-9325-4B3D-92C7-042AF0A73A8D Q33397882-F13E099D-466B-4615-9178-B6B0FEE09AA0 Q33419208-F94C8F97-DDFC-4D38-BEB6-2F179ED1D80C Q33574671-AAD186D1-BB6D-4DD3-ACDE-895B18EBE6CE Q33677718-A7EA38A9-70F5-4A38-98FB-95875894FCCD Q33739315-A6E2D475-A2B8-4978-96B5-1A3AA26AA283 Q33747791-ED4BA476-93A4-4E6B-BA82-F4CE9629EDF8 Q33818216-43250B33-A048-4C6D-B02A-91EE7268FB66 Q34003280-041F89AB-CDC8-4C9B-A3DE-6A414AA0F93A Q34029102-5079DA3C-4739-4331-90E4-F43BDC9A1859 Q34043846-3D839602-C805-4899-9A05-A0A23F3C1B26 Q34224709-3BBF1364-D724-4D69-A0C8-8FEA169806DF Q34249937-FAD9BEB2-D868-4D9F-8BF3-2FF923563E75 Q34417553-11193854-C908-4A6C-B2BC-616EAD13417D Q34450251-8919EC1A-CE5C-4616-9598-501481E184B0 Q34538249-70366E92-D2F1-4ECB-9619-5DDF662E164F Q34568403-C5D27D04-0E68-4CED-9F14-96EEF91BF485 Q34614005-8F0C8DA2-349F-4CC7-B23A-2543697D220A Q34634513-D88F77C0-98D3-4A63-8B81-ABB6F5AE60D1 Q34714063-98989D9B-DED7-45F4-A105-F1AA36D85EE8 Q34794683-641C22F7-18B6-46C9-AC2A-5EBB1FDBC715 Q34812877-DD1F087C-E450-445E-9D97-E09ADCD2F26A Q34845927-0298D18E-E73B-4EBF-ABEC-5C7CFD90FDC9

P2860

Circulating Th17, Th22, and Th1 cells are increased in psoriasis

http://www.wikidata.org/entity/Q24629315

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Circulating Th17, Th22, and Th1 cells are increased in psoriasis

@ast

Circulating Th17, Th22, and Th1 cells are increased in psoriasis

@en

Circulating Th17, Th22, and Th1 cells are increased in psoriasis

@nl

type

label

Circulating Th17, Th22, and Th1 cells are increased in psoriasis

@ast

Circulating Th17, Th22, and Th1 cells are increased in psoriasis

@en

Circulating Th17, Th22, and Th1 cells are increased in psoriasis

@nl

prefLabel

Circulating Th17, Th22, and Th1 cells are increased in psoriasis

@ast

Circulating Th17, Th22, and Th1 cells are increased in psoriasis

@en

Circulating Th17, Th22, and Th1 cells are increased in psoriasis

@nl

P1433

Q24629315-05BBBB0B-4FF8-4319-9FAA-C298F78D4EA6

P1476

Q24629315-CB641101-D169-4E94-9051-13790EC0BAAA

P2093

Q24629315-0BAA1126-C7AD-417C-A31C-DD08FF47F02B

Q24629315-12EF5EB2-9E2E-4090-94E1-8F540C6F402C

Q24629315-825E649C-D083-4D8A-A62A-6C0992645F3E

Q24629315-BB29136D-D97A-49D6-8463-6461C233B266

Q24629315-D459757F-8A61-4A71-A85C-37A462B70E33

P2860

Q24629315-01B781CC-C1C6-46E4-9179-AD9CCDB3FA61

Q24629315-0ABAC25F-DBB2-4BDD-BAD2-36F38EA5EF05

Q24629315-2687E9FE-4594-4121-B530-BACC1164E1DA

Q24629315-37DE0421-7CE8-4335-939E-034ED7BFF886

Q24629315-3CF9EC9D-D613-4A8F-BA3D-9EADCB7C5C10

Q24629315-3F516BA0-DE0E-41F3-A15B-BF05747822AB

Q24629315-3F930124-F7F2-4482-9620-641DC5EF1A3A

Q24629315-42A0C7B4-2856-4A2E-B710-7EC1024E2336

Q24629315-4B8047CC-1FFD-40ED-99D5-0994A7CCA3E5

Q24629315-4C0D8ECA-D1ED-4F95-947B-18E918DA08D3

P2888

Q24629315-77BE4BD0-6CDB-4CD2-970B-790EA89461E0

P304

Q24629315-4B8D2BDC-FB71-44AB-B188-A17C6049E942

P31

Q24629315-4588B00D-54A2-44F2-A89E-8153D54139C2

P3181

Q24629315-A0D33AAC-E2BB-4986-96FD-4BCC5CE59997

P356

Q24629315-09850ADA-BF5A-4BED-A7C2-9DE02CDA778B

P407

Q24629315-B4B2DCE8-B00A-4040-979A-C7DE24361275

P433

Q24629315-3DF0E124-87D5-4060-9439-F913EBF1406C

P478

Q24629315-7250A2D2-DBCB-4D79-B607-C35F424ECE74

P577

Q24629315-8732200F-A009-4FD5-BBF4-96B83AF0A880

P5875

Q24629315-9000A348-C7A5-4FC1-A931-1C6428223166

P6179

Q24629315-526362E7-2871-4D3E-8D13-F3EADA9211EA

P698

Q24629315-244D83A3-8246-469F-AB86-115715126CD7

P921

Q24629315-DCB3C2B1-C985-41BD-B8EE-7E28E1092FF9

P932

Q24629315-13615F5A-2196-421C-9560-6D9C37BC7922

P3181

P356

P1433

Journal of Investigative Dermatology

P1476

Circulating Th17, Th22, and Th1 cells are increased in psoriasis

@en

P2093

Andrew Blauvelt

http://www.w3.org/2001/XMLSchema#string

Heather L Rizzo

http://www.w3.org/2001/XMLSchema#string

Jennifer J Lee

http://www.w3.org/2001/XMLSchema#string

Shinji Kagami

http://www.w3.org/2001/XMLSchema#string

Yoshinobu Koguchi

http://www.w3.org/2001/XMLSchema#string

P2860

Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways

STAT3 and NF-kappaB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice

Memory IL-22-producing CD4+ T cells specific for Candida albicans are present in humans

Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis

Interleukin-17 and type 17 helper T cells

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome

Development, cytokine profile and function of human interleukin 17-producing helper T cells

Phenotypic and functional features of human Th17 cells

P2888

P304

1373-83

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1378971

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/JID.2009.399

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

130

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40768466

http://www.w3.org/2001/XMLSchema#string

P6179

1039472341

http://www.w3.org/2001/XMLSchema#string

P698

20032993

http://www.w3.org/2001/XMLSchema#string

P921

P932

2892169

http://www.w3.org/2001/XMLSchema#string